Title an Updated Review of Methods and Advancements In
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
What Is Optical Imaging?
What is Optical Imaging? Optical imaging uses light to interrogate cellular and molecular function in the living body, as well as in animal and plant tissue. The information is ultimately derived from tissue composition and biomolecular processes. Images are generated by using photons of light in the wavelength range from ultraviolet to near infrared. Contrast is derived through the use of: exogenous agents (i.e., dyes or probes) that provide a signal endogenous molecules with optical signatures (i.e., NADH, hemoglobin, collagens, etc.) reporter genes. Florescence Imaging Fluorescence protein imaging uses endogenous or exogenous molecules or materials that emit light when activated by an external light source such as a laser. An external light of appropriate wavelength is used to excite a target molecule, which then fluoresces by releasing longer-wavelength, lower-energy light. Fluorescence imaging provides the ability to localize and measure gene expression including normally expressed and aberrant genes, proteins and other pathophysiologic processes. Other potential uses include cell trafficking, tagging superficial structures, detecting lesions and for monitoring tumor growth and response to therapy. Bioluminescent Imaging (BLI) Bioluminescent imaging uses a natural light-emitting protein such as luciferase to trace the movement of certain cells or to identify the location of specific chemical reactions within the body. Bioluminescent imaging is being applied to both gene expression and therapeutic monitoring. Optical Imaging Technologies Near-infrared fluorescence imaging involves imaging fluorescence photons in the near-infrared range (typically 600– 900 nm). A fluorochrome is excited by a lower wavelength, light source and the emitted excitation is recorded as a slightly higher wavelength with a high sensitivity charge-coupled-device (CCD) camera. -
A Remote and Non-Contact Method for Obtaining the Blood-Pulse Waveform with a Laser Doppler Vibrometer*
A remote and non-contact method for obtaining the blood-pulse waveform with a laser Doppler vibrometer* Candida L. Desjardins 1, Lynn T. Antontelli 2, Edward Soares 1,3 1 Department of Mathematics and Computer Science, College of the Holy Cross, Worcester, MA 2 Naval Undersea Warfare Center, 1176 Howell St., Newport, R.I. 3 Department of Radiology, University of Massachusetts Medical School, Worcester MA ABSTRACT The use of lasers to remotely and non-invasively detect the blood pressure waveform of humans and animals would provide a powerful diagnostic tool. Current blood pressure measurement tools, such as a cuff, are not useful for burn and trauma victims, and animals require catheterization to acquire accurate blood pressure information. The purpose of our sensor method and apparatus invention is to remotely and non-invasively detect the blood pulse waveform of both animals and humans. This device is used to monitor an animal or human’s skin in proximity to an artery using radiation from a laser Doppler vibrometer (LDV). This system measures the velocity (or displacement) of the pulsatile motion of the skin, indicative of physiological parameters of the arterial motion in relation to the cardiac cycle. Tests have been conducted that measures surface velocity with an LDV and a signal-processing unit, with enhanced detection obtained with optional hardware including a retro-reflector dot. The blood pulse waveform is obtained by integrating the velocity signal to get surface displacement using standard signal processing techniques. Continuous recording of the blood pulse waveform yields data containing information on cardiac health and can be analyzed to identify important events in the cardiac cycle, such as heart rate, the timing of peak systole, left ventricular ejection time and aortic valve closure. -
Supplement 197: Ophthalmic Optical Coherence Tomography for Angiographic Imaging Storage SOP Classes
Digital Imaging and Communications in Medicine (DICOM) Supplement 197: Ophthalmic Optical Coherence Tomography for Angiographic Imaging Storage SOP Classes Prepared by: DICOM Standards Committee 1300 N. 17th Street Suite 900 Rosslyn, Virginia 22209 USA Final Text VERSION: April 5, 2017 Developed pursuant to DICOM Work IteM: 2016-04-A Supplement 197 – Ophthalmic Optical Coherence Tomography for Angiographic Imaging Storage SOP Classes Page 2 Table of Contents Table of Contents ............................................................................................................................................................. 2 Scope and Field of Application ......................................................................................................................................... 3 Changes to NEMA Standards Publication PS 3.2 ............................................................................................................ 4 Part 2: Conformance ........................................................................................................................................................ 4 Changes to NEMA Standards Publication PS 3.3 ............................................................................................................ 5 Part 3: Information Object Definitions .............................................................................................................................. 5 A.aa Ophthalmic Optical Coherence Tomography En Face Image Information Object Definition .................... -
Quantitative Micro-Computed Tomography Imaging of Vascular Dysfunction in Progressive Kidney Diseases
BASIC RESEARCH www.jasn.org Quantitative Micro-Computed Tomography Imaging of Vascular Dysfunction in Progressive Kidney Diseases † †‡ † Josef Ehling,* Janka Bábícková, Felix Gremse,* Barbara M. Klinkhammer, † | Sarah Baetke,* Ruth Knuechel, Fabian Kiessling,* Jürgen Floege,§ Twan Lammers,* ¶ and †‡ Peter Boor § *Institute for Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany; †Institute of Pathology, Medical Faculty, RWTH Aachen University, Aachen, Germany; ‡Institute of Molecular Biomedicine, Comenius University, Bratislava, Slovakia; §Department of Nephrology, Medical Faculty, RWTH Aachen University, Aachen, Germany; |Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; and ¶Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands ABSTRACT Progressive kidney diseases and renal fibrosis are associated with endothelial injury and capillary rarefaction. However, our understanding of these processes has been hampered by the lack of tools enabling the quantitative and noninvasive monitoring of vessel functionality. Here, we used micro-computed tomography (mCT) for anatomical and functional imaging of vascular alterations in three murine models with distinct mechanisms of progressive kidney injury: ischemia-reperfusion (I/R, days 1–56), unilateral ureteral obstruction (UUO, days 1–10), and Alport mice (6–8 weeks old). Contrast-enhanced in vivo mCT enabled robust, non- invasive, and longitudinal monitoring of vessel functionality and revealed a progressive decline of the renal relative blood volume in all models. This reduction ranged from 220% in early disease stages to 261% in late disease stages and preceded fibrosis. Upon Microfil perfusion, high-resolution ex vivo mCT allowed quanti- tative analyses of three-dimensional vascular networks in all three models. -
Synchrotron Microangiography Studies of Angiogenesis in Mice with Microemulsions and Gold Nanoparticles
Anal Bioanal Chem (2010) 397:2109–2116 DOI 10.1007/s00216-010-3775-8 ORIGINAL PAPER Synchrotron microangiography studies of angiogenesis in mice with microemulsions and gold nanoparticles Chia-Chi Chien & C. H. Wang & C. L. Wang & E. R. Li & K. H. Lee & Y. Hwu & Chien-Yi Lin & Shing-Jyh Chang & C. S. Yang & Cyril Petibois & G. Margaritondo Received: 7 February 2010 /Revised: 17 April 2010 /Accepted: 22 April 2010 /Published online: 6 June 2010 # Springer-Verlag 2010 Abstract We present an effective solution for the problem provides the best contrast and minimal distortion of the of contrast enhancement in phase-contrast microangiogra- circulation and vessel structure. Such emulsions are phy, with the specific objective of visualising small reasonably biocompatible and, with sizes of 0±0.8 µm, (<8 µm) vessels in tumor-related microangiogenesis. sufficient to diffuse to the smallest vessel and still provide Different hydrophilic and hydrophobic contrast agents were reasonable contrast. We also explored the use of Au explored in this context. We found that an emulsified nanoparticle colloids that could be used not only to enhance version of the hydrophobic contrast agents Lipiodol® contrast but also for interesting applications in nano- medicine. Both the Lipiodol microemulsions and Au nanoparticle colloids can be conjugated with medicines or C.-C. Chien : C. H. Wang : C. L. Wang : E. R. Li : K. H. Lee : Y. Hwu (*) cell specific labeling agents and their small size can allow Institute of Physics, Academia Sinica, the study of the diffusion of contrast agents through the Nankang, vessel leakage. This enables direct imaging of drug delivery Taipei 115, Taiwan, China which is important for cancer treatment. -
Three-Dimensional Diffuse Optical Tomography in The
Three-dimensional diffuse optical tomography in the parallel plane transmission geometry: Evaluation of a hybrid frequency domainÕcontinuous wave clinical system for breast imaging J. P. Culvera),b) R. Choe, M. J. Holboke, L. Zubkov, T. Durduran, and A. Slemp Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6396 V. Ntziachristosb) and B. Chance Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6396 A. G. Yodh Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6396 ͑Received 12 March 2002; accepted for publication 5 November 2002; published 23 January 2003͒ Three-dimensional diffuse optical tomography ͑DOT͒ of breast requires large data sets for even modest resolution ͑1cm͒. We present a hybrid DOT system that combines a limited number of frequency domain ͑FD͒ measurements with a large set of continuous wave ͑cw͒ measurements. The FD measurements are used to quantitatively determine tissue averaged absorption and scattering coefficients. The larger cw data sets (105 measurements͒ collected with a lens coupled CCD, permit 3D DOT reconstructions of a 1-liter tissue volume. To address the computational complexity of large data sets and 3D volumes we employ finite difference based reconstructions computed in parallel. Tissue phantom measurements evaluate imaging performance. The tests include the fol- lowing: point spread function measures of resolution, characterization of the size and contrast of single objects, field of view measurements and spectral characterization of constituent concentra- tions. We also report in vivo measurements. Average tissue optical properties of a healthy breast are used to deduce oxy- and deoxy-hemoglobin concentrations. Differential imaging with a tumor simulating target adhered to the surface of a healthy breast evaluates the influence of physiologic fluctuations on image noise. -
High-Resolution Optical Imaging: Progress and Perspectives
Molecular Imaging Summit imaging techniques. Nonetheless, high effective tissue presence of specific enzymes or a change in pH or concentrations can be achieved using ‘‘bulk carriers,’’ such other environmental variables. NEWSLINE as vesicles and macromolecular constructs in which the (4) Cell labels, which may be either inside or attached to number of paramagnetic species can be concentrated. specific cells, that then rely on the trafficking of the Susceptibility agents based on iron oxide particles have cells to be localized. At high resolution in animals, a greater effective relaxivity but affect transverse relaxation single labeled cells have been detected using this rates (1/T2), which are typically 10–30 times greater than approach. longitudinal (1/T1) rates. An alternative mechanism for affecting water MR signals is by magnetization transfer with labile protons on other species, notably amide groups Topical Issues in proteins or in agents designed to provide a large reser- The potential applications of these different approaches voir of exchangeable protons (such as dendrimers). The are intriguing, but the practical success to date of detecting chemical exchange by saturation transfer (CEST) effect is specific molecular targets has been limited. The prospects interesting, partly because the contrast produced can be for achieving sufficiently high levels of contrast material to switched ‘‘on’’ and ‘‘off’’ in a controlled manner. be seen reliably in clinical applications are poor compared MR contrast agents proposed to date can be classified with other modalities. Success will rely on combining into the following categories: improved designs for more effective relaxation agents and carrier vehicles that can deliver relatively large amounts of (1) Nonspecific contrast agents, such as lanthanide che- the agent to a target region. -
How Newly-Formed Blood Vessels Stopped by the Mineral Blocks of Bone Substitutes Can Be Avoided by Using Innovative Combined Therapeutics
biomedicines Article Mechanistic Illustration: How Newly-Formed Blood Vessels Stopped by the Mineral Blocks of Bone Substitutes Can Be Avoided by Using Innovative Combined Therapeutics Fabien Bornert 1,2,3,†, François Clauss 1,2,3,†, Guoqiang Hua 1,2,†, Ysia Idoux-Gillet 1,2,†, Laetitia Keller 1,2,†, Gabriel Fernandez De Grado 1,2,3,†, Damien Offner 1,2,3 , Rana Smaida 1,2, Quentin Wagner 1,2, Florence Fioretti 1,2,3, Sabine Kuchler-Bopp 1,2 , Georg Schulz 4, Wolfgang Wenzel 5, Luca Gentile 1,2, Laurent Risser 6, Bert Müller 4 , Olivier Huck 1,2,3 and Nadia Benkirane-Jessel 1,2,3,* 1 INSERM (French National Institute of Health and Medical Research) UMR 1260, Regenerative Nanomedicine, CRBS, 1 Rue Eugène Boeckel, 67000 Strasbourg, France; [email protected] (F.B.); [email protected] (F.C.); [email protected] (G.H.); [email protected] (Y.I.-G.); [email protected] (L.K.); [email protected] (G.F.D.G.); [email protected] (D.O.); [email protected] (R.S.); [email protected] (Q.W.); fi[email protected] (F.F.); [email protected] (S.K.-B.); [email protected] (L.G.); [email protected] (O.H.) 2 Faculty of Dental Surgery, University of Strasbourg, University Hospital Strasbourg (HUS), 8 Rue de Sainte Elisabeth, 67000 Strasbourg, France 3 Department of Pediatric Dentistry, University Hospital Strasbourg (HUS), 1 Place de l’Hôpital, Citation: Bornert, F.; Clauss, F.; Hua, 67000 Strasbourg, France 4 G.; Idoux-Gillet, Y.; Keller, L.; Biomaterials Science Center, University of Basel, Gewerbestrasse 14, CH-4123 Allschwil, Switzerland; Fernandez De Grado, G.; Offner, D.; [email protected] (G.S.); [email protected] (B.M.) 5 Smaida, R.; Wagner, Q.; Fioretti, F.; Institute of Nanotechnology, Karlsruhe Institute of Technology, Campus North, Building 640, DE-76131 Karlsruhe, Germany; [email protected] et al. -
Endothelial TLR4 Activation Impairs Intestinal Microcirculatory Perfusion in Necrotizing Enterocolitis Via Enos–NO–Nitrite Signaling
Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS–NO–nitrite signaling Ibrahim Yazjia,b, Chhinder P. Sodhia,b, Elizabeth K. Leea,b, Misty Goodc,d, Charlotte E. Egana,b, Amin Afrazia,b, Matthew D. Neala,b, Hongpeng Jiaa,b, Joyce Lina,b, Congrong Maa,b, Maria F. Brancaa,b, Thomas Prindlea,b, Ward M. Richardsonb, John Ozoleke,f, Timothy R. Billiarb, David G. Biniong, Mark T. Gladwinh,i, and David J. Hackama,b,1 Divisions of aPediatric Surgery, cNewborn Medicine, and ePathology, Children’s Hospital of Pittsburgh, Pittsburgh, PA 15224; and Departments of bSurgery, dPediatrics, and fPathology and Divisions of gGastroenterology and hPulmonary, Allergy, and Critical Care Medicine, and iVascular Medicine Institute, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261 Edited by Ruslan Medzhitov, Yale University School of Medicine, New Haven, CT, and approved April 12, 2013 (received for review November 16, 2012) Necrotizing enterocolitis (NEC) is a devastating disease of pre- (NO), which is generated through the activity of endothelial NO mature infants characterized by severe intestinal necrosis and for synthase (eNOS) (6). Recent studies have shown that NO can which breast milk represents the most effective protective strat- also be generated through conversion from sodium nitrite egy. Previous studies have revealed a critical role for the lipopoly- within the diet through the activity of commensal microbes (7). saccharide receptor toll-like receptor 4 (TLR4) in NEC development Given that TLR4 is expressed on endothelial cells (8), we now through its induction of mucosal injury, yet the reasons for which hypothesize that TLR4 signaling within the endothelium plays intestinal ischemia in NEC occurs in the first place remain unknown. -
Association of Remote Imaging Photoplethysmography And
OPEN Association of remote imaging photoplethysmography and cutaneous perfusion in volunteers Stefan Rasche1*, Robert Huhle2, Erik Junghans2, Marcelo Gama de Abreu2, Yao Ling3, Alexander Trumpp3 & Sebastian Zaunseder4 Remote imaging photoplethysmography (iPPG) senses the cardiac pulse in outer skin layers and is responsive to mean arterial pressure and pulse pressure in critically ill patients. Whether iPPG is sufciently sensitive to monitor cutaneous perfusion is not known. This study aimed at determining the response of iPPG to changes in cutaneous perfusion measured by Laser speckle imaging (LSI). Thirty-seven volunteers were engaged in a cognitive test known to evoke autonomic nervous activity and a Heat test. Simultaneous measurements of iPPG and LSI were taken at baseline and during cutaneous perfusion challenges. A perfusion index (PI) was calculated to assess iPPG signal strength. The response of iPPG to the challenges and its relation to LSI were determined. PI of iPPG signifcantly increased in response to autonomic nervous stimuli and to the Heat test by 5.8% (p = 0.005) and 11.1% (p < 0.001), respectively. PI was associated with LSI measures of cutaneous perfusion throughout experiments (p < 0.001). iPPG responses to study task correlated with those of LSI (r = 0.62, p < 0.001) and were comparable among subjects. iPPG is sensitive to autonomic nervous activity in volunteers and is closely associated with cutaneous perfusion. Monitoring tissue perfusion is a pivotal concern in critically ill patients 1. Besides the recently proposed vital microscopy of the sublingual circulation2, the cutaneous microcirculation is a useful “body window to the cir- culation” and may indicate global perfusion defcits early in critical illness by clinical signs like skin mottling or prolonged capillary reflling3–6. -
Biomedical Optical Imaging
Chapter 17. Biomedical Optical Imaging Biomedical Optical Imaging Academic Staff Professor James G. Fujimoto Research Staff and Visiting Scientists Dr. Yueli Chen, Dr. Iwona Gorczynska, Dr. Ben Potsaid, Dr. Chao Zhou Scientific Collaborators Dr. Jay S. Duker, M.D., Joseph Ho, Varsha Manjunath, (New England Eye Center) Dr. Joel Schuman, M.D. (University of Pittsburgh Medical Center) Dr. Allen Clermont, Dr. Edward Feener (Joslin Diabetes Center) Dr. Hiroshi Mashimo, M.D. (VA Medical Center) Dr. Joseph Schmitt (LightLab Imaging) Dr. David A. Boas, Lana Ruvinskaya, Dr. Anna Devor (MGH) Alex Cable, Dr. James Jiang, Dr. Ben Potsaid (Thorlabs, Inc.) Graduate Students Desmond C. Adler, Aaron D. Aguirre, M.D., Hsiang-Chieh Lee, Jonathan J. Liu, Vivek J. Srinivasan, Tsung-Han Tsai Technical and Support Staff Dorothy A. Fleischer, Donna L. Gale Research Areas and Projects 1. Optical coherence tomography (OCT) technology 1.1 Overview of Optical Coherence Tomography 1.2 Spectral / Fourier domain OCT Imaging 1.3 Swept source / Fourier domain OCT Imaging using Swept Lasers 2. OCT in Ophthalmology 2.1 OCT in Ophthalmology 2.2 Technology Ophthalmic OCT 2.3 Ultrahigh Speed Spectral / Fourier Domain OCT Retinal Imaging 2.4 Swept Source / Fourier domain OCT Imaging at 1050 nm Wavelengths 2.5 Clinical OCT Studies Quantitative OCT measurements of retinal structure En Face projection OCT Interactive Science Publication (ISP) Clinical Studies of Retinal Disease 2.6 Functional OCT Imaging in Human Retina 2.7 Small Animal Retinal Imaging 3. High Speed Three-Dimensional OCT Endoscopic Imaging 3.1 OCT imaging of the Esophagus 3.2 OCT imaging of the Lower GI Tract 3.3 Assessment of Therapies in the GI Tract 3.5 Novel contrast agents for OCT 4. -
July 1 2017 Annual Scientific Meeting
Undersea & Hyperbaric Medical Society’s 2017 ANNUAL SCIENTIFIC MEETING 2017 Annual Scientific Meeting June 29 – July 1 Pre-courses: June 28 / Post-course: July 2 Wound Care Education Partners NAPLES GRANDE BEACH RESORT, NAPLES, FLORIDA Wednesday, June 28: How to Prepare for Accreditation: Royal Palm Ballroom I Hyperbaric Oxygen Safety: Clinical and Technical Issues: Royal Palm Ballroom II Management of DCI in the Field and Development of Best Practice: Royal Palm Ballroom III Welcome Reception: Mangrove Pool side Thursday, June 29: Exhibits: Orchid Ballroom Posters: Royal Palm Foyer General Session: Royal Palm IV-VIII Non-Physician Breakout Session: Royal Palm I-III Friday, June 30: Exhibits: Orchid Ballroom Posters: Royal Palm Foyer General Session: Royal Palm IV-VIII Saturday, July 1: Exhibits: Orchid Ballroom Posters: Royal Palm Foyer General Session: Royal Palm IV-VIII Sunday, July 2: Reimbursement Rollercoaster: Acacia 4-6 Surveyor Training: Acacia 1-3 UHMS Annual Scientific Meeting * June 29-July 1, 2017 * Naples, Florida 2 TABLE OF CONTENTS Subject Page No. UHMS Committee Leadership Listing .......................................................................................................................... 4 Schedules Pre-Courses .................................................................................................................................................. 5-6 Non-Physician Breakout Track ....................................................................................................................